SNP Array Analysis of Borderline Melanocytic Tumors

Explore the application of SNP array analysis in diagnosing borderline melanocytic tumors through this informative 24-minute conference talk presented at the 2022 Cancer Genomics Consortium Annual Meeting. Dive into the complexities of clinical cancer genomics as Dr. Katherine Geiersbach discusses the latest advancements in SNP array technology for accurately identifying genomic alterations in challenging melanocytic lesions. Gain insights into best practices for clinical cancer genomic testing and learn how this cutting-edge approach can improve diagnostic accuracy and guide appropriate treatment decisions for patients with ambiguous melanocytic tumors. Discover the role of the Cancer Genomics Consortium in promoting education and advancing the field of clinical cancer genomics to ensure more precise diagnoses and personalized therapies for cancer patients.

SNP Array Analysis of Borderline Melanocytic Tumors